Aetna stops paying Bextra drug claims
Key points
- Health insurer Aetna Inc. said on Monday it is not paying any claims for Bextra, a pain reliever that the FDA requested to be removed from the market, for prescriptions as of April 7.
- The Hartford-based company said it is contacting more than 33,000 customers who have used Bextra to inform them of the U.S.
- Pfizer Inc. agreed to suspend sales of Bextra after U.S. and European regulators said the side effects, including a potentially fatal skin allergy, outweigh the benefits.
- Aetna Pharmacy Management has instituted computer system edits that will automatically block Bextra prescriptions from being paid.
Health insurer Aetna Inc. said on Monday it is not paying any claims for Bextra, a pain reliever that the FDA requested to be removed from the market, for prescriptions as of April 7.
The Hartford-based company said it is contacting more than 33,000 customers who have used Bextra to inform them of the U.S. Food and Drug Administration's (FDA) decision to ask that Bextra be withdrawn from the market.
Pfizer Inc. agreed to suspend sales of Bextra after U.S. and European regulators said the side effects, including a potentially fatal skin allergy, outweigh the benefits.
Aetna Pharmacy Management has instituted computer system edits that will automatically block Bextra prescriptions from being paid.
Besides the direct communications, Aetna Pharmacy Management will communicate the news concerning Bextra and increased warnings the FDA is requiring of all Cox-2 inhibitors and non-steroidal anti-inflammatory drugs, such as ibuprofen and naproxen, on its corporate and pharmacy Web sites in an attempt to reach all members.
The FDA has been studying the safety of Cox-2 inhibitors since Merck & Co. Inc. voluntarily recalled Vioxx in September 2004 after a clinical study showed an increased risk of cardiovascular problems.
Written and revised by
Gerald Hurowitz, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Addiction →NewsMedicare prescription drug abuse a problem: GAO
Prescription drug abuse by elderly and disabled beneficiaries of Medicare cost the U.S. program nearly $150 million in 2008, highlighting an area where the government can seek to save health costs. According to a…
6 October 2011
NewsOld anti-smoking drug passes new test
Cytisine, an extract from the seeds of the Golden Rain acacia that was first marketed in Bulgaria in 1964, can give smokers an inexpensive assist in kicking the habit, according to the first large modern study of the…
30 September 2011
NewsPopular colorectal cancer drug may cause permanent nerve damage
Oxaliplatin, a platinum-based anticancer drug that's made enormous headway in recent years against colorectal cancer, appears to cause nerve damage that may be permanent and worsens even months after treatment ends. The…
29 September 2011
